NL-OMON32962已完成不适用
A MULTIPLE ASCENDING DOSE PHARMACOLOGY, FOOD EFFECT AND DRUG INTERACTION STUDY OF LY2562175 IN HEALTHY ADULT SUBJECTS - LY2562175 MAD/DDI/FE study
Chorus, Lilly Research Laboratories0 个研究点目标入组 57 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 57
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy men or women of non child bearing potential
- •18 - 65 year inclusive
- •BMI 18-30 kg/m2
排除标准
- •Zie vraag 5b
研究者
相似试验
已完成
1 期
Part C: A Study of SGR-1505 in Healthy Volunteer ParticipantsActivated B-cell diff use large B-cell lymphoma (ABC-DLBCL)Cancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaACTRN12623000464662Schrödinger, Inc.12
已完成
不适用
A Single and Multiple Ascending Dose, Placebo-Controlled, Double-Blind, Phase 1 Study of KY1005 in Healthy Volunteers10003816NL-OMON45487Kymab Limited64
已完成
1 期
The effect of food on the pharmacokinetcs, tolerability and pharmacodynamics of BNC210 in healthy male volunteersGeneralised Anxiety DisorderMental Health - AnxietyACTRN12610000442000Bionomics Limited4
进行中（未招募）
1 期
A PLACEBO-CONTROLLED, ESCALATING DOSE, MULTIPLE DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PREGABALIN IN PEDIATRIC PATIENTS WITH PARTIAL ONSET SEIZURESPARTIAL ONSET SEIZURESMedDRA version: 12.1Level: LLTClassification code 10034089Term: Partial seizures NOSEUCTR2010-020730-26-FRPfizer Inc.235 East 42nd Street, New York, NY 1001765
已完成
1 期
To know the amount of the drug and safety of Brimonidine Tartarate ophthalmic suspensioCTRI/2019/03/018023Sun Pharma Advanced Research Company Limited13